FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/096858 [Registered on: 03/11/2025] Trial Registered Prospectively
Last Modified On: 31/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Total intraoperative fentanyl consumption comparison in modified radical mastectomy patients under general anaesthesia 
Scientific Title of Study   Comparison of surgical pleth index guided analgesia with conventional analgesia technique for total intraoperative fentanyl consumption in patients undergoing modified radical mastectomy under general anaesthesia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Riya Choudhary  
Designation  PG Resident  
Affiliation  ABVIMS and Dr. RML Hospital  
Address  Room no. 301 3rd floor Depatment of Anaesthesia ABVIMS and Dr. RML HOSPITAL

Central
DELHI
110001
India 
Phone  9929482426  
Fax    
Email  Riyachoudhary260698@gmai.com  
 
Details of Contact Person
Scientific Query
 
Name  Akhilesh gupta 
Designation  Professor  
Affiliation  ABVIMS and Dr RML Hospital  
Address  Room no. 301 3rd floor Depatment of Anaesthesia ABVIMS and Dr. RML HOSPITAL

Central
DELHI
110001
India 
Phone  9810685426  
Fax    
Email  Drakhileshgupta@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Akhilesh gupta 
Designation  Professor  
Affiliation  ABVIMS and Dr RML Hospital  
Address  Room no. 301 3rd floor Depatment of Anaesthesia ABVIMS and Dr. RML HOSPITAL

Central
DELHI
110001
India 
Phone  9810685426  
Fax    
Email  Drakhileshgupta@gmail.com  
 
Source of Monetary or Material Support  
ABVIMS and Dr. RML Hospital,Baba Kharak Singh Marg,Near Gurudwara Bangla sahib,Connaught place,New Delhi,Delhi 110001 central Delhi 
 
Primary Sponsor  
Name  ABVIMS and dr Ram Manohar Lohia hospital  
Address  Baba Kharar Singh marg,near gurudwara bangla sahib,Connaught place,,central Delhi,new delhi 110001 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrRiya Choudhary   ABVIMS and Dr RML Hospital,New Delhi   Room no. 301 3rd floor Depatment of Anaesthesia ABVIMS and Dr. RML HOSPITAL,Central Delhi 110001
Central
DELHI 
9929482426

Riyachoudhary260698@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee ABVIMS and Dr. RML Hospital,New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional analgesia   Conventional analgesia will be given and intraoperative fentanyl Consumption will be noted 
Intervention  Surgical pleth index guided analgesia   Surgical pleth index guided analgesia will be given and intraoperative fentanyl consumption will be noted 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  ASA physical status 1 or 2
BMI between 18.5 and 30 kg/m2 
 
ExclusionCriteria 
Details  Allergy or hypersensitivity to fentanyl or study drugs
Chronic opioid use or analgesic dependence
Cardiovascular instability
Autonomic dysfunction or peripheral vascular disease
Severe hepatic or renal impairment
Pregnant or lactating women 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Total intraoperative fentanyl consumption in microgram will be measured in surgical pleth index guided analgesia technique and conventional analgesia technique   Baseline HR and SBP will be noted then intraoperative HR,SBP and fentanyl total doses will be noted 
 
Secondary Outcome  
Outcome  TimePoints 
1.Postoperative pain score in the form of numerical rating score(NRS) in recovery
2.Incidence of post operative nausea vomiting in recovery  
After the surgery is over that is post operative  
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   11/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This prospective randomised parallel group interventional trial will include female patients aged 18-65 years

Two groups will be formed 

Group 1 SPI Guided-fentanyl 0.5 microgram/kg admistered whenever SPI greater than 50

Group 2 Conventional- Fentanyl 0.5 micrograms/kg given hourly after induction and additionally if HR or SBP rise greater than 20 percent from baseline

All patients will undergo standardised anaesthesia induction with midazolam fentanyl propofol and vecuronium and maintenance with sevoflurane titrated to maintain entropy between 40-60

The primary outcome will be total intraoperative fentanyl consumption.
 
Close